Bolt Biotherapeutics
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $5 | $26 | $2,500 | $2,169 |
Gross Profit | 5 | -177 | 2,500 | 2,169 |
EBITDA | -7,549 | -7,041 | -6,376 | -6,854 |
EBIT | -7,720 | -7,244 | -6,631 | -7,144 |
Net Income | -7,720 | -7,244 | -6,631 | -7,144 |
Net Change In Cash | 5 | 26 | 2,500 | 2,169 |
Free Cash Flow | -6,553 | -8,023 | -7,156 | -9,804 |
Cash | 12,860 | 11,609 | 11,703 | 17,753 |
Basic Shares | 1,690 | 1,869 | 1,869 | 1,919 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $7,695 | $7,690 | $7,876 | $5,729 |
Gross Profit | 6,204 | 7,690 | -53,666 | -67,394 |
EBITDA | -32,085 | -66,455 | -67,343 | -86,432 |
EBIT | -33,376 | -68,236 | -69,197 | -88,098 |
Net Income | -33,376 | -63,118 | -69,197 | -88,098 |
Net Change In Cash | 7,695 | 7,690 | 7,876 | 5,729 |
Free Cash Flow | -39,922 | -61,330 | -69,731 | -78,457 |
Cash | 11,703 | 7,205 | 10,810 | 9,244 |
Basic Shares | 1,869 | 1,909 | 1,891 | 1,868 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$4.57 |
2026-03-31 | -$4.31 |
2025-12-31 | -$2.98 |
2025-09-30 | -$3.72 |